Soligenix Investor Relations Material
Latest events
Q1 2025
8 May, 2025
Q4 2024
21 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Soligenix Inc
Access all reports
Soligenix Inc is a U.S.-based biopharmaceutical company focused on developing and commercializing treatments for rare diseases and biodefense indications. The company works on therapies for inflammatory conditions, oncology, and infectious diseases, with both proprietary drug candidates and government-supported programs. The company is headquartered in Princeton, New Jersey, and its shares are listed on the NASDAQ.
)
)
)